{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T10:09:20Z","timestamp":1648634960862},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1994,1,1]],"date-time":"1994-01-01T00:00:00Z","timestamp":757382400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother. Pharmacol."],"published-print":{"date-parts":[[1994]]},"DOI":"10.1007\/bf00686116","type":"journal-article","created":{"date-parts":[[2004,11,28]],"date-time":"2004-11-28T16:10:48Z","timestamp":1101658248000},"page":"75-78","source":"Crossref","is-referenced-by-count":1,"title":["Weekly 5-fluorouracil and high-dose folinic acid in combination with epidoxorubicin as first-line therapy in advanced breast cancer: a phase II study"],"prefix":"10.1007","volume":"34","author":[{"given":"Herbert","family":"St\ufffdger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Bauerhofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Katrin","family":"Kasparek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renate","family":"Moser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferdinand","family":"Ploner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elke","family":"Derstvenscheg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"Kuss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martini","family":"Wilders-Truschnig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Steindorfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Rosanelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hellmut","family":"Samonigg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","unstructured":"Allegra JC, Sholar PW, Drake JC, Bagley C, Lippman ME, Chabner BA (1986) A phase II trial for the treatment of metastatic breast cancer with 5-fluorouracil (5-FU) and leucovorin. Proceedings, Symposium on the Development of Folates and Folic Acid Antagonists in Cancer Chemotherapy, Innisbrook Tarpon Springs, January 23?26, 1986, p 5"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-1-4684-5607-3_10","volume-title":"The expanding role of folates and fluoropyrimidines in cancer chemotherapy","author":"CJ Allegra","year":"1988","unstructured":"Allegra CJ, Egan GF, Drake JC, et al (1988) The treatment of metastatic breast cancer with 5-fluorouracil and leucovorin. In: Rustum Y, McGuire J (eds) The expanding role of folates and fluoropyrimidines in cancer chemotherapy. Plenum, New York, pp 107?110"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000226434","volume":"44","author":"G Beretta","year":"1987","unstructured":"Beretta G, Locatelli C, Tabiadon D, et al (1987) Epirubicin treatment of advanced breast carcinoma with the weekly low-dose regimen. Oncology 44: 6?12","journal-title":"Oncology"},{"key":"CR4","first-page":"261","volume":"70","author":"C Brambilla","year":"1986","unstructured":"Brambilla C, Rossi A, Bonfante V, et al (1986) Phase II study of doxorubicin versus epirubicin in advanced breast cancer. Cancer Treat Rep 70: 261?266","journal-title":"Cancer Treat Rep"},{"key":"CR5","first-page":"96","volume":"6","author":"TH Doroshow","year":"1987","unstructured":"Doroshow TH, Bertrand M, Multhauf P, et al (1987) Prospective randomized trial comparing 5-FU versus 5-FU and high dose folinic acid (HDFA for treatment of advanced colorectal cancer (abstract). Proc Am Soc Clin Oncol 6: 96","journal-title":"Proc Am Soc Clin Oncol"},{"key":"CR6","first-page":"82","volume":"5","author":"C Erlichman","year":"1986","unstructured":"Erlichman C, Fine S, Wong A, et al (1986) A comparison of 5-fluorouracil (5-FU) and folinic acid (FA) versus 5-FU in metastatic colorectal cancer (MCC) (abstract). Proc Soc Clin Oncol 5: 82","journal-title":"Proc Soc Clin Oncol"},{"key":"CR7","first-page":"1249","volume":"71","author":"JL Grem","year":"1987","unstructured":"Grem JL, Hoth DF, Hamilton JM, King SA, Leyland-Jones B (1987) Overview of current status and future direction of clinical trials with 5-fluorouracil in combination with folinic acid. Cancer Treat Rep 71: 1249?1264","journal-title":"Cancer Treat Rep"},{"key":"CR8","first-page":"914","volume-title":"Cancer, principles and practice of oncology","author":"S Hellman","year":"1982","unstructured":"Hellman S, Harris J, Canellos GP, et al (1982) Cancer of the breast. In: De Vita V, Hellman S, Rosenberg S (eds) Cancer, principles and practice of oncology. J. B. Lippincott, Philadelphia, pp 914?970"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1056\/NEJM198001033020104","volume":"302","author":"IC Henderson","year":"1980","unstructured":"Henderson IC, Cancellos GP (1980) Cancer of the breast ? the past decade. N Engl J Med 302: 17?30, 78?90","journal-title":"N Engl J Med"},{"key":"CR10","first-page":"34","volume":"14","author":"IC Henderson","year":"1987","unstructured":"Henderson IC, Hayes DF, Come S, et al (1987) New agents and new medical treatments for advanced breast cancer. Semin Oncol 14: 34?64","journal-title":"Semin Oncol"},{"key":"CR11","first-page":"101","volume":"2","author":"B Hoogstraten","year":"1979","unstructured":"Hoogstraten B, Fabian C (1979) A reappraisal of single drugs in advanced breast cancer. Cancer Clin Trials 2: 101?109","journal-title":"Cancer Clin Trials"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1200\/JCO.1988.6.6.976","volume":"6","author":"Italian Multicenter Breast Study with Epirubicin","year":"1988","unstructured":"Italian Multicenter Breast Study with Epirubicin (1988) Phase III randomized study of fluorouracil, epirubicin and cyclophosphamide in advanced breast cancer: an Italian multicenter trial. J Clin Oncol 6: 976?982","journal-title":"J Clin Oncol"},{"key":"CR13","first-page":"675","volume":"68","author":"WS Jones","year":"1984","unstructured":"Jones WS, Mattson W (1984) Phase-II study of weekly-low doses of 4-epi-doxorubicin in advanced postmenopausal breast cancer. Cancer Treat Rep 68: 675?677","journal-title":"Cancer Treat Rep"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1200\/JCO.1986.4.5.685","volume":"4","author":"D Machover","year":"1986","unstructured":"Machover D, Goldschmidt E, Chollet P, et al (1986) Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high dose folinic acid. J Clin Oncol 4: 685?696","journal-title":"J Clin Oncol"},{"key":"CR15","first-page":"373","volume":"13","author":"G Marini","year":"1987","unstructured":"Marini G, Zaniboni A, Gorni F, Marpicati P, Montini E, Simoncini E (1987) Clinical experience with 5-fluorouracil (5-FU) and high-dose folinic acid in solid tumors. Drugs Exp Clin Res 13: 373?376","journal-title":"Drugs Exp Clin Res"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1200\/JCO.1987.5.10.1559","volume":"5","author":"N Petrelli","year":"1987","unstructured":"Petrelli N, Herrera L, Rustum YM, et al (1987) A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma. J Clin Oncol 5: 1559?1565","journal-title":"J Clin Oncol"},{"key":"CR17","first-page":"197","volume":"28","author":"ME Scheulen","year":"1987","unstructured":"Scheulen ME, Niederle N, Schmidt CG (1987) Weekly low-dose epirubicin treatment of metastatic breast cancer (abstract). Proc Am Assoc Cancer Res 28: 197","journal-title":"Proc Am Assoc Cancer Res"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1200\/JCO.1989.7.7.890","volume":"7","author":"SM Swain","year":"1989","unstructured":"Swain SM, Lippman ME, Eagan EF, et al (1989) Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer. J Clin Oncol 7: 890?899","journal-title":"J Clin Oncol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/1097-0142(19821001)50:7<1235::AID-CNCR2820500703>3.0.CO;2-L","volume":"50","author":"DC Tormey","year":"1982","unstructured":"Tormey DC, Gelman R, Band PR, Sears M, Rosenthal SN, Dewys W, Perlia C, Rice MA (1982) Comparison of induction chemotherapies for metastatic breast cancer. Cancer 50: 1235?1244","journal-title":"Cancer"},{"key":"CR20","series-title":"Offset publication","volume-title":"Handbook for reporting results of cancer treatment","author":"WHO","year":"1979","unstructured":"WHO (1979) Handbook for reporting results of cancer treatment. Offset publication 48. WHO, Geneva"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/0277-5379(89)90408-2","volume":"25","author":"A Zaniboni","year":"1989","unstructured":"Zaniboni A, Simoncini E, Marpicati P, Montini E, Ferrari V, Ferragni A, Boari L, Marini G (1989) Cyclophosphamide, epirubicin, high-dose folinic acid and 5-fluorouracil (super-FEC) as first-line chemotherapy for advanced breast cancer: preliminary results. Eur J Clin Oncol 25: 1151?1155","journal-title":"Eur J Clin Oncol"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00686116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00686116\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00686116","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T10:10:46Z","timestamp":1554459046000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00686116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1994]]}},"alternative-id":["BF00686116"],"URL":"https:\/\/doi.org\/10.1007\/bf00686116","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994]]}}}